Clinical Trial Update: Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cetuximab alone or with docetaxel to treat prostate cancer before prostatectomy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Cetuximab (Erbitux) (Cetuximab)
• Docetaxel (Taxotere) (docetaxel)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Prostatic Neoplasms | Phase 2 | Status: TERMINATED